Narodowy Instytut Onkologii - Oddzial w Gliwicach-Breast Unit ( Site 1811)

Gliwice, Silesian Voivodeship 44-101

0 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) — Running, not enrolling